Log in
NASDAQ:RAPT

RAPT Therapeutics Insider Trades

$37.45
+0.74 (+2.02 %)
(As of 09/18/2020 12:00 AM ET)
Add
Compare
Today's Range
$36.49
Now: $37.45
$37.53
50-Day Range
$21.60
MA: $27.36
$37.05
52-Week Range
$10.52
Now: $37.45
$51.21
Volume350,502 shs
Average Volume139,011 shs
Market Capitalization$916.36 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Insider Trades

RAPT Therapeutics (NASDAQ:RAPT) Insider Buying and Selling Activity

Insider Ownership Percentage: 31.00%
Insider Buying (Last 12 Months): $9,570,765.00
Insider Selling (Last 12 Months): $1,182,091.21

Insider Buying and Selling by Quarter


RAPT Therapeutics (NASDAQ RAPT) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/15/2020William HoInsiderSell1,000$36.14$36,140.0066,858  
9/1/2020William HoInsiderSell1,000$26.24$26,240.0067,858  
8/17/2020William HoInsiderSell1,000$24.76$24,760.0068,858  
8/3/2020William HoInsiderSell1,000$21.54$21,540.0069,858  
7/24/2020Wendye RobbinsDirectorBuy900$22.47$20,223.005,050  
7/15/2020William HoInsiderSell1,000$28.76$28,760.0070,858  
7/1/2020Wendye RobbinsDirectorBuy2,600$26.01$67,626.003,550  
7/1/2020William HoInsiderSell1,000$28.61$28,610.0071,858  
6/29/2020Wendye RobbinsDirectorBuy1,600$25.77$41,232.003,550  
6/25/2020Karen C LamVPSell875$35.00$30,625.0012,735  
6/25/2020Michael F GiordanoDirectorSell19,013$33.37$634,463.8110,069  
6/15/2020William HoInsiderSell1,000$20.95$20,950.0072,858  
6/1/2020William HoInsiderSell1,000$18.50$18,500.0073,858  
5/22/2020William HoInsiderSell7,500$18.02$135,150.00  
5/15/2020Dirk G. BrockstedtInsiderSell9,877$15.00$148,155.00  
5/7/2020Karen C. LamVPSell1,831$15.40$28,197.40  
11/4/2019Brian Russell WongCEOBuy25,000$14.49$362,250.00
11/4/2019Group Ii Lp ColumnMajor ShareholderBuy625,000$14.49$9,056,250.00
11/4/2019Wendye RobbinsDirectorBuy1,600$14.49$23,184.00
(Data available from 1/1/2013 forward)
This page was last updated on 9/20/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.